(Q54105197)

English

In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

bacterial isolate

1 reference

based on heuristic

inferred from title

Arthur L. Barry

2

object named as

Barry AL

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

1

object named as

Fuchs PC

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

Steven D. Brown

3

object named as

Brown SD

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

33

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

33-38

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900134-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900134-5

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900134-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900134-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900134-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae. Interpretive criteria and comparisons with Etest results

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900134-5

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900134-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral bioavailability of trovafloxacin with and without food in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900134-5

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900134-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900134-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(98)00134-5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9990473

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54105197&oldid=1940492261"